Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittlin

Showing results (281-290 of 318) with videos related to

Pageof 32
Sort By:
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Science Translational Medicine|July 17, 2015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaMargaret A Phillips, Julie Lotharius, Kennan Marsh, et al.
ACS Central Science|November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAlice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Science Translational Medicine|July 22, 2021
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistanceJames M Murithi, Cécile Pascal, Jade Bath, et al.
Science Translational Medicine|April 28, 2017
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinaseTanya Paquet, Claire Le Manach, Diego González Cabrera, et al.
Nature|June 10, 2016
Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Nature|June 19, 2015
A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Physical Review Letters|February 15, 2001
First symmetry tests in polarized Z0 decays to bbgK Abe, K Abe, T Abe, et al.
Physical Review Letters|March 24, 2005
Direct measurements of Ab and Ac using vertex and kaon charge tags at the SLAC detectorKoya Abe, Kenji Abe, T Abe, et al.
Pageof 32

Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Science Translational Medicine|July 17, 2015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaMargaret A Phillips, Julie Lotharius, Kennan Marsh, et al.
ACS Central Science|November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAlice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Science Translational Medicine|July 22, 2021
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistanceJames M Murithi, Cécile Pascal, Jade Bath, et al.
Science Translational Medicine|April 28, 2017
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinaseTanya Paquet, Claire Le Manach, Diego González Cabrera, et al.
Nature|June 10, 2016
Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Nature|June 19, 2015
A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Physical Review Letters|February 15, 2001
First symmetry tests in polarized Z0 decays to bbgK Abe, K Abe, T Abe, et al.
Physical Review Letters|March 24, 2005
Direct measurements of Ab and Ac using vertex and kaon charge tags at the SLAC detectorKoya Abe, Kenji Abe, T Abe, et al.
Pageof 32